arc-02
arc-02: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: CG Oncology, Inc. (CGON)
Development Pipeline (1)
| Company | Phase |
|---|---|
| CG Oncology, Inc. (CGON) | Phase 1 |
Clinical Trials (1)
A Study to Evaluate Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity of ARC-02 in Adult Participants With B-cell Non-Hodgkins Lymphoma (NHL)
Frequently asked questions
Who is developing arc-02?
arc-02 is being developed by CG Oncology, Inc..
How many clinical trials involve arc-02?
BioSniper tracks 1 clinical trial involving arc-02.
Analyze CG Oncology, Inc. & arc-02 with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company